# Modulating One-Carbon Metabolism with B-Vitamins to Protect the Retinal Barrier and Prevent Retinal Degeneration

**Authors:** Hossameldin Abouhish, Lamiaa Shalaby, Omar Elzayat, Neelesh Peddireddy, Amany Tawfik

PMC · DOI: 10.3390/nu18020236 · 2026-01-12

## TL;DR

This study shows that B-vitamin deficiency disrupts retinal blood barriers and causes retinal damage, but these effects can be reversed with B-vitamin supplementation.

## Contribution

The study demonstrates that B-vitamin supplementation can restore retinal vascular integrity disrupted by B-vitamin deficiency.

## Key findings

- B-vitamin deficiency caused elevated homocysteine and retinal vascular leakage in mice.
- B-vitamin supplementation restored retinal barrier integrity and reduced albumin leakage.
- Deficiency led to decreased tight junction proteins, indicating blood-retinal barrier disruption.

## Abstract

Background/Objectives: Vitamin B12 deficiency is increasingly recognized as a contributor in both vascular and neurodegenerative aging-related disorders. Its deficiency disrupts one-carbon metabolism, leading to impaired homocysteine (Hcy) cycling. Elevated Hcy is a well-established risk factor for vascular dysfunction. Previously, we established that elevated Hcy contributes to aging retinal diseases and plays a central role in blood retinal barrier (BRB) dysfunction. Building on this foundation, the present study examines how B-vitamin deficiency disrupts one-carbon metabolism and whether restoring these vitamins can serve as a preventive or therapeutic strategy. Since B-vitamins (B6, B9, and B12) are crucial cofactors in the metabolism of Hcy, we investigated how dietary changes in these vitamins affect serum Hcy levels and retinal vascular integrity in mice. Methods: C57BL/6- Wild-type (WT) and cbs+/− mice (Cystathionine Beta-Synthase heterozygotes, common mouse model for elevated Hcy) were fed specially formulated diets, which contained different levels of B-vitamins (normal, deficient (B-Vit (−)) or enriched (B-Vit (+)). Initially, two groups of mice were placed on either a normal or a deficient diet. After 12–16 weeks, the success of the diet regimes was confirmed by observing serum B12 deficiency in the B-Vit (−) group, along with elevated Hcy levels. Subsequently, a subgroup of the B-Vit (−) mice was switched to an enriched diet. The BRB integrity was evaluated in living mice using fluorescein angiography (FA), optical coherence tomography (OCT), and in the perfused mice retinas with Western blot analysis of leaked retinal albumin and tight junction proteins (occludin and ZO-1) levels. Results: The B-vitamin deficiency caused significant drop in serum vitamin B12 and an increase in plasma Hcy, leading to vascular leakage, altered retinal thickness, choroidal neovascular changes, increased retinal albumin leak, and decreased tight junction protein expression, indicating BRB disruption, which was restored with B-vitamin supplementation. Conclusions: a long-term deficiency of vitamins B6, B9, and B12 can lead to disruptions in the BRB. However, supplementation with these B-vitamins has the potential to reverse these effects and help maintain the integrity of BRB. This under-score the significance of one-carbon metabolism for retinal health and suggests that ensuring adequate levels of B-vitamins may aid in preventing aging retinal diseases with BRB disruption such as diabetic retinopathy and age-related macular degeneration.

## Linked entities

- **Proteins:** si:ch73-61d6.3 (uncharacterized si:ch73-61d6.3), TJP1 (tight junction protein 1)
- **Chemicals:** homocysteine (PubChem CID 778), B9 (PubChem CID 8830), B12 (PubChem CID 54605677)
- **Diseases:** diabetic retinopathy (MONDO:0005266), age-related macular degeneration (MONDO:0005150)
- **Species:** Mus musculus (taxon 10090)

## Full-text entities

- **Genes:** Actb (actin, beta) [NCBI Gene 11461] {aka Actx, E430023M04Rik, beta-actin}, Tjp1 (tight junction protein 1) [NCBI Gene 21872] {aka ZO1}, Grin1 (glutamate receptor, ionotropic, NMDA1 (zeta 1)) [NCBI Gene 14810] {aka GluN1, GluRdelta1, GluRzeta1, M100174, NMD-R1, NMDAR1}, Cbs (cystathionine beta-synthase) [NCBI Gene 12411] {aka HIP4}, Blnk (B cell linker) [NCBI Gene 17060] {aka BASH, Bca, Ly-57, Ly57, Lyw-57, SLP-65}, Ocln (occludin) [NCBI Gene 18260] {aka Ocl}, Alb (albumin) [NCBI Gene 11657] {aka Alb-1, Alb1, BCL001, BCL002, BPL001}
- **Diseases:** pupil dilation (MESH:D011681), vascular alterations (MESH:D057772), vascular abnormalities (MESH:D014652), retinal vein occlusion (MESH:D012170), microvascular disorders (MESH:D017566), BRB impairment (MESH:D012164), deficiency (MESH:D007153), Parkinson's disease (MESH:D010300), renal disease (MESH:D007674), neurovascular damage (MESH:D013901), inflammation (MESH:D007249), metabolic (MESH:D008659), disorders (MESH:D009358), diabetic (MESH:D003920), metabolic disturbance (MESH:D024821), age-related disorders (MESH:D008569), choroidal neovascularization (MESH:D020256), Alzheimer's disease (MESH:D000544), DR (MESH:D003930), BRB (MESH:D012173), nutritional deficiency (MESH:D044342), cognitive dysfunction (MESH:D003072), cardiovascular disease (MESH:D002318), injury to (MESH:D014947), type 2 diabetes (MESH:D003924), B (MESH:D006509), folate (MESH:C562799), Vascular Leakage (MESH:D003763), neuronal loss (MESH:D009410), loss (MESH:D016388), malabsorption (MESH:D008286), Retinal Degeneration (MESH:D012162), B-vitamin deficiencies (MESH:D014804), proliferative retinopathy (OMIM:603933), cystathionine beta-synthase ( (MESH:D006712), B12 deficiency (MESH:D014806), mitochondrial dysfunction (MESH:D028361), AMD (MESH:D008268), dietary deficiency (MESH:D000740), vascular dysfunction (MESH:D002561), retinopathy (MESH:D058437), neuroinflammatory (MESH:D000090862), age-related vascular and neurodegenerative diseases (MESH:D019636)
- **Chemicals:** 3,3',5,5'-tetramethylbenzidine (MESH:C021758), isoflurane (MESH:D007530), folate (MESH:D005492), tropicamide (MESH:D014331), Tween-20 (MESH:D011136), carbon (MESH:D002244), B12 (MESH:C034730), PVDF (MESH:C024865), Hcy (MESH:D006710), ROS (MESH:D017382), oxygen (MESH:D010100), fluorescein (MESH:D019793), methionine (MESH:D008715), B-Vit (-) (-), hypromellose (MESH:D065347), biotin (MESH:D001710), B (MESH:D001895), vitamin B6 (MESH:D025101), pyridoxine (MESH:D011736), SDS (MESH:D012967), B9 (MESH:C014499), nitrogen (MESH:D009584), Vitamin B12 (MESH:D014805), amino acid (MESH:D000596)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116], Mus musculus (house mouse, species) [taxon 10090]
- **Cell lines:** C57BL/6 — Mus musculus (Mouse), Transformed cell line (CVCL_C0MU), RPE — Homo sapiens (Human), Spontaneously immortalized cell line (CVCL_IQ82), /6 — Homo sapiens (Human), Tongue squamous cell carcinoma, Cancer cell line (CVCL_5985)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12854450/full.md

---
Source: https://tomesphere.com/paper/PMC12854450